Suppr超能文献

丙型肝炎病毒取代乙型肝炎病毒成为持续性慢性肝炎的病因。

Displacement of hepatitis B virus by hepatitis C virus as the cause of continuing chronic hepatitis.

作者信息

Liaw Y F, Tsai S L, Chang J J, Sheen I S, Chien R N, Lin D Y, Chu C M

机构信息

Liver Unit, Chang Gung Memorial Hospital, Taipei, Taiwan.

出版信息

Gastroenterology. 1994 Apr;106(4):1048-53. doi: 10.1016/0016-5085(94)90766-8.

Abstract

BACKGROUND/AIMS: It has been shown that hepatitis C virus (HCV) superinfection may suppress hepatitis B virus (HBV) leading to hepatitis B surface antigen (HBsAg) clearance and that hepatitis may persist after HBsAg clearance in a few patients. The role of HCV in continuing hepatitis after termination of chronic HBsAg antigenemia remains to be explored in a series of patients.

METHODS

HCV markers were studied using second generation enzyme immunoassay and polymerase chain reaction with reverse transcription and were compared between 41 patients with persistent alanine aminotransferase (ALT) elevation (hepatitis group) and 82 age/sex-matched patients with normal ALT (control group) after HBsAg clearance.

RESULTS

Twenty-six (63%) of the 41 hepatitis group patients were seropositive for antibodies to HCV (anti-HCV) compared with only 4 (5%) of 82 controls (P < 0.0001). Six patients of the hepatitis group and 1 control had an episode of acute hepatitis C with seroconversion of anti-HCV 1-68 months before HBsAg clearance. Of those seropositive for anti-HCV, serum HBV DNA was not detectable, and serum HCV RNA was detected in 23 (88.5%) of the 26 hepatitis patients but none of the 4 controls (P < 0.001). Liver biopsy in 6 anti-HCV positive patients with continuing hepatitis showed features compatible with chronic hepatitis C. HCV RNA, but not HBV DNA, was detected in liver tissues of these 6 patients.

CONCLUSIONS

The results suggest that HCV may usurp the role of HBV in chronic hepatitis and act as the major cause of continuing hepatitis or ALT elevation after HBV/HBsAg clearance.

摘要

背景/目的:已有研究表明,丙型肝炎病毒(HCV)重叠感染可能抑制乙型肝炎病毒(HBV),导致乙型肝炎表面抗原(HBsAg)清除,且少数患者在HBsAg清除后肝炎仍会持续。在一系列患者中,HCV在慢性HBsAg血症终止后持续肝炎中的作用仍有待探索。

方法

采用第二代酶免疫测定和逆转录聚合酶链反应研究HCV标志物,并在41例持续性丙氨酸氨基转移酶(ALT)升高的患者(肝炎组)和82例年龄/性别匹配的ALT正常患者(对照组)HBsAg清除后进行比较。

结果

41例肝炎组患者中有26例(63%)抗HCV抗体(抗-HCV)血清学阳性,而82例对照组中只有4例(5%)(P<0.0001)。肝炎组6例患者和1例对照在HBsAg清除前1 - 68个月发生急性丙型肝炎,抗-HCV血清学转换。在抗-HCV血清学阳性者中,未检测到血清HBV DNA,26例肝炎患者中有23例(88.5%)检测到血清HCV RNA,而4例对照组均未检测到(P<0.001)。6例抗-HCV阳性且肝炎持续的患者肝活检显示符合慢性丙型肝炎的特征。这6例患者的肝组织中检测到HCV RNA,但未检测到HBV DNA。

结论

结果表明,HCV可能在慢性肝炎中取代HBV的作用,并成为HBV/HBsAg清除后持续肝炎或ALT升高的主要原因。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验